Toxicological Aspects of Synthetic Drugs

Presented April 2013 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

The Analog Dilemma with Synthetic Cannabinoids

April 23, 2013 (View the recorded presentation)
Presented by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Increasing Diversity of Chemicals in Synthetic Stimulant and Cathinone Cases

Presented November 27, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Challenges of Method Validation for Hallucinogens & Designer Stimulants in Biological Samples Using LC-TOF

Hosted by Agilent Technologies, October 8, 2012
Presented by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Briefing on Synthetic and Designer Drugs

U.S. Rep. Patrick Meehan's Synthetic Drug Use Forum, May 29, 2012
Presented by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Trends Report on Changes in the Designer Drug Market: Spring 2012

A live webinar hosted on May 23, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

The Challenges of Analytical Method Validation of Designer Drugs in Non-Biological Samples by GC/MS

Hosted by Agilent Technologies, May 15, 2012
Presented by Fran Diamond, NMS Labs Chemistry Technical Leader

Pharmacodynamics and Pharmacokinetics of Synthetic Cannabinoids

Presented at the AAFS Annual Conference, February 2012, by Dr. Barry K. Logan, Dr. Wendy Adams

Designer Drugs Testing Solutions for Employers

Presented February 1, 2012 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

The Expanding Reach of the Designer Drug Movement in 2011: Analytical and Interpretive Challenges for
Forensic Toxicology and Chemistry

A live webinar hosted on October 26, 2011 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Developments in Toxicology Support for the DRE Community

Co-hosted by NMS Labs and Draeger Safety Diagnostics, Inc., July 2011
 Presented by Dr. Barry K. Logan

Oral Fluid as a Chemical Test for the DRE Program: History, the Future, and Practical Considerations

Presented at the IACP-DRE Conference, July 2011, by Dr. Barry K. Logan

Identification of Markers of JWH-018 and JWH-073 Use in Human Urine

by Sherri L. Kacinko, Allan Xu, Matthew M. McMullin, Barry K. Logan

K2 and Beyond: A Synthetic Cannabinoid Primer

Presented at the AAFS Annual Conference, February 2011 ,by Dr. Barry K. Logan, Lindsay Reinhold, Dr. Sherri Kacinko

K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis webinar

Presented September 16, 2010 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Salvia - Effects, Legal Status and Analysis webinar

Presented March 18, 2010 by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

New Highs: Salvia and K2 Solutions for the DRE Program

Presented July 2010 at the IACP DRE Conference to Drug Recognition Experts across the nation
by Dr. Barry K. Logan, PhD, DABFT, NMS Labs National Director of Forensic Services

Bisphenol-A and Other Suspected Estrogenic Endocrine Disruptors

View presentations from the dinner that NMS Labs hosted during the 2010 Endocrine Society's Annual Meeting